Stephan Siebel is an Endocrinology/Metabolic physician affiliated with Yale University. OpenAlex indexes 30 publications with 451 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
330 Cedar St # 3103
New Haven, CT 065103218
Telephone
252-847-4268Registry record last updated 21 Jul 2022.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
49.1%Statin24.5%Atorvastatin Calcium100%Part D<11 patientsCalcium channel blocker24.5%Amlodipine Besylate100%Part D<11 patientsMetabolism & gastrointestinal
26.4%Proton pump inhibitor26.4%Pantoprazole Sodium100%Part D<11 patientsRespiratory
24.5%Leukotriene Receptor Antagonist24.5%Montelukast Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Elevation of hepatic de novo lipogenesis in mice with overnutrition is dependent on multiple substrates
Journal of Lipid Research
2025 - Spatial Partitioning of Glucose Metabolism Supports Tissue-Specific Metabolic Programs In Vivo
bioRxiv (Cold Spring Harbor Laboratory)
2025 - Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer
Breast Cancer Research and Treatment
2024
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Thomas McGlashan, MD
Yale University
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”